Nuclear Receptor LXR Alpha, beta (C-Term) Antikörper

Produktnummer ABIN2315376

Der Kaninchen Polyklonal anti-Nuclear Receptor LXR Alpha, beta Antikörper (ABIN2315376) detektiert spezifisch Nuclear Receptor LXR Alpha, beta in WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für Nuclear Receptor LXR Alpha, beta (C-Term) Antikörper (ABIN2315376)

Target: Nuclear Receptor LXR Alpha, beta

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails

Bindungsspezifität: C-Term

Kreuzreaktivität: Human, Maus, Ratte (Rattus)

Kreuzreaktivität (Details): Calculated cross reactivity: Hu Mo Rt

Produktmerkmale: Nuclear Receptor LXR alpha, beta (Liver X Receptor alpha, Liver X Receptor beta, LX Receptor alpha, LX receptor beta, LXRa, LXRalpha, LXRb, LXRbeta, NERI, NR1H2, NR1H3, Nuclear Orphan Receptor LXR alpha, Nuclear Orphan Receptor LXR beta, Nuclear Receptor NER, Nuclear Receptor Subfamily 1 Group H Member 2, Nuclear Receptor Subfamily 1 Group H Member 3, Oxysterols Receptor LXR alpha, Oxysterols Receptor LXR beta, RIP15, RLD-1, Ubiquitously Expressed Nuclear Receptor, UNR)

Aufreinigung: Purified by immunoaffinity chromatography.

Immunogen: Synthetic peptide corresponding to a sequence at the C-terminal of human LXRa, identical to the related rat and mouse sequence.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute with sterile dH2O.

Buffer: Supplied as a lyophilized powder from PBS, pH 7.4, 5 % BSA, 0.05 % thimerosal, 0.05 % sodium azide.

Konservierungsmittel: Sodium azide, Thimerosal (Merthiolate)

Vorsichtsmaßnahmen: This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: -20°C

Antigendetails

Target: Nuclear Receptor LXR Alpha, beta